State Street’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

State Street’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-33,280	Closed	-$9.35K	–	4374
2024 Q3	$9.35K	Hold	33,280	–	–	﹤0.01%	4266
2024 Q2	$25K	Hold	33,280	–	–	﹤0.01%	4254
2024 Q1	$16.2K	Hold	33,280	–	–	﹤0.01%	4305
2023 Q4	$27.3K	Buy	33,280 +4,261	+15%	+$8.66K	﹤0.01%	4301
2023 Q3	$86.5K	Hold	29,019	–	–	﹤0.01%	4144
2023 Q2	$43K	Buy	29,019 +26,920	+1,283%	+$36.7K	﹤0.01%	4458
2023 Q1	$2.58K	Hold	2,099	–	–	﹤0.01%	4778
2022 Q4	$4.22K	Hold	2,099	–	–	﹤0.01%	4836
2022 Q3	$22K	Hold	2,099	–	–	﹤0.01%	4820
2022 Q2	$39K	Buy	+2,099	New	+$42.8K	﹤0.01%	4774

Other funds holding NVOS

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

State Street's NVOS Position: Q4 2024 in Review

State Street sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 33,280 shares — an estimated $9.35K sold.

State Street first reported a position in NVOS in Q2 2022 and held it in 10 quarters. The position peaked at $86.5K in Q3 2023. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

State Street reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
State Street sold 33,280 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $9.35K.
State Street first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q2 2022 and held it in 10 quarters.
State Street's Novo Integrated Sciences, Inc. Common Stock position peaked at $86.5K in Q3 2023.
1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.